Delivery Order SPE2DR25D3505-SPE2DR26F96D7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,258.30 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens, with performance in Conshohocken, Pennsylvania and completion targeted for December 3, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and...
- The Defense Logistics Agency awarded a delivery order valued at $3,051.81 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injector pens. This competitively awarded, firm fixed-price contract was executed on December 30, 2025, with an ultimate completion date of December 31, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to lower...
- The Defense Logistics Agency awarded a delivery order valued at $2,648.59 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of September 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement, particularly for military and veteran healthcare systems. The place of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,696.37 firm fixed-price delivery order for Repatha 140 mg/ml SureClick auto-injector pens, with performance in Conshohocken, Pennsylvania and completion scheduled for November 12, 2025. This competitive award, issued on November 10, 2025, carries no set-aside designation and represents a child order under AmerisourceBergen's broader contract vehicle with DLA. This delivery order falls under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order valued at $18,133.57 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order fulfillment. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a $7,931.56 delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injector pens. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 5, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. Repatha is a prescription medication used to lower cholesterol levels in patients with cardiovascular disease,...
- The Defense Logistics Agency awarded a delivery order valued at $91,189.21 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injector pens. This firm fixed-price, non-set-aside contract was awarded on November 12, 2025, with an ultimate completion date of November 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Repatha is a prescription medication used to treat high cholesterol in patients at risk for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,762.29 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens. The contract, awarded on December 11, 2025, with an ultimate completion date of December 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor on this award. Repatha is a prescription medication used to...
- The Defense Logistics Agency awarded a delivery order valued at $2,498.31 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This competitively awarded, firm fixed price delivery order, issued on December 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a delivery order valued at $15,153.17 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens. The contract, issued on June 2, 2025, with completion targeted for June 3, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award. This delivery order is a child contract executed under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- SPE2DR25D3505Indefinite Delivery Contract
- SPE2DR25D3505-SPE2DR26F96D7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,588.75 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens on December 30, 2025, with a completion date of December 31, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete successfully for federal pharmaceutical procurement requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor in the federal medical supply chain, specializing in pharmaceutical distribution for military and veteran healthcare systems. Repatha is a prescription medication used for cholesterol management, and its procurement through DLA supports the broader Defense Health Agency pharmaceutical supply needs. The delivery of this specialty medication through AmerisourceBergen's established pharmaceutical prime vendor relationship underscores the company's role in supplying brand-name and specialized medical products across multiple therapeutic domains to support military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 12/29/25 |